These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12561554)

  • 21. Immunogenicity of therapeutic monoclonal antibodies.
    Pendley C; Schantz A; Wagner C
    Curr Opin Mol Ther; 2003 Apr; 5(2):172-9. PubMed ID: 12772508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Process analytics for purification of monoclonal antibodies.
    Flatman S; Alam I; Gerard J; Mussa N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):79-87. PubMed ID: 17161664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and safety of recombinant anti-RhD in healthy RhD-negative male volunteers.
    Bichler J; Spycher MO; Amstutz HP; Andresen I; Gaede K; Miescher S
    Transfus Med; 2004 Apr; 14(2):165-71. PubMed ID: 15113381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of LC-MS for quantitative analysis and metabolite identification of therapeutic oligonucleotides.
    Lin ZJ; Li W; Dai G
    J Pharm Biomed Anal; 2007 Jun; 44(2):330-41. PubMed ID: 17339091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunodiagnosis of lung cancer with monoclonal antibodies.
    Egri G; Takáts A
    Med Sci Monit; 2005 Sep; 11(9):RA296-300. PubMed ID: 16127376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of tandem Biacore-mass spectrometry to identify platelet membrane targets of novel monoclonal antibodies.
    Ravanat C; Wurtz V; Ohlmann P; Fichter M; Cazenave JP; Vandorsselaer A; Lanza F; Gachet C
    Anal Biochem; 2009 Mar; 386(2):237-43. PubMed ID: 19135971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant bispecific antibodies for cancer therapy.
    Kontermann RE
    Acta Pharmacol Sin; 2005 Jan; 26(1):1-9. PubMed ID: 15659107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manufacturing of recombinant therapeutic proteins in microbial systems.
    Graumann K; Premstaller A
    Biotechnol J; 2006 Feb; 1(2):164-86. PubMed ID: 16892246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein.
    Lappin G; Garner RC; Meyers T; Powell J; Varley P
    J Pharm Biomed Anal; 2006 Jun; 41(4):1299-302. PubMed ID: 16554138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biotechnologic drugs and chemotherapy for infectious diseases].
    Honorato J
    Rev Esp Quimioter; 2007 Sep; 20(3):310-6. PubMed ID: 18080027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays.
    Wood L; Ducroq DH; Fraser HL; Gillingwater S; Evans C; Pickett AJ; Rees DW; John R; Turkes A
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):380-8. PubMed ID: 18583623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the conserved oligosaccharides of recombinant monoclonal antibodies on the separation by protein A and protein G chromatography.
    Gaza-Bulseco G; Hickman K; Sinicropi-Yao S; Hurkmans K; Chumsae C; Liu H
    J Chromatogr A; 2009 Mar; 1216(12):2382-7. PubMed ID: 19181325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies.
    Lin JH
    Curr Drug Metab; 2009 Sep; 10(7):661-91. PubMed ID: 19702530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometry and HPLC with fluorescent detection-based orthogonal approaches to characterize N-linked oligosaccharides of recombinant monoclonal antibodies.
    Lucka AW; Kilgore BR; Patel R; Andrien BA; Dhume ST
    Methods Mol Biol; 2008; 446():347-61. PubMed ID: 18373269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety evaluation of biotechnology derived products.
    Galbraith WM
    Prog Clin Biol Res; 1987; 235():3-14. PubMed ID: 3474670
    [No Abstract]   [Full Text] [Related]  

  • 36. Plant biopharming of monoclonal antibodies.
    Ko K; Koprowski H
    Virus Res; 2005 Jul; 111(1):93-100. PubMed ID: 15896408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of monoclonal antibodies for the assessment of protein purification by recombinant ribosomal coupling.
    Kristensen J; Sperling-Petersen HU; Mortensen KK; Sørensen HP
    Int J Biol Macromol; 2005 Dec; 37(4):212-7. PubMed ID: 16330094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the glycosylation state of a recombinant monoclonal antibody using weak cation exchange chromatography and mass spectrometry.
    Gaza-Bulseco G; Bulseco A; Chumsae C; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 862(1-2):155-60. PubMed ID: 18164669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS; Jakubowski N
    Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient strategies for the conjugation of oligonucleotides to antibodies enabling highly sensitive protein detection.
    Kozlov IA; Melnyk PC; Stromsborg KE; Chee MS; Barker DL; Zhao C
    Biopolymers; 2004 Apr; 73(5):621-30. PubMed ID: 15048786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.